Applying quantitative structure-activity relationship (QSAR) methodology for modeling postmortem redistribution of benzodiazepines and tricyclic antidepressants.
暂无分享,去创建一个
Anna Tsantili-Kakoulidou | Stamatios Theocharis | Constantinos Giaginis | A. Tsantili-Kakoulidou | S. Theocharis | C. Giaginis
[1] Fumiyoshi Yamashita,et al. In silico approaches for predicting ADME properties of drugs. , 2004, Drug metabolism and pharmacokinetics.
[2] O. Drummer,et al. Postmortem Drug Analysis: Analytical and Toxicological Aspects , 2002, Therapeutic drug monitoring.
[3] Ronald Eugene Shaffer,et al. Multi‐ and Megavariate Data Analysis. Principles and Applications, I. Eriksson, E. Johansson, N. Kettaneh‐Wold and S. Wold, Umetrics Academy, Umeå, 2001, ISBN 91‐973730‐1‐X, 533pp. , 2002 .
[4] H. Bonnell,et al. Postmortem Drug Redistribution. , 2001, Forensic science review.
[5] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[6] F. Moriya,et al. Redistribution of basic drugs into cardiac blood from surrounding tissues during early-stages postmortem. , 1999, Journal of forensic sciences.
[7] R A Braithwaite,et al. Estimating antemortem drug concentrations from postmortem blood samples: the influence of postmortem redistribution , 2000, Journal of clinical pathology.
[8] E. Spina,et al. Metabolic drug interactions with newer antipsychotics: a comparative review. , 2007, Basic & clinical pharmacology & toxicology.
[9] R. Ferner,et al. Post-mortem clinical pharmacology. , 2008, British journal of clinical pharmacology.
[10] Ivonne M C M Rietjens,et al. Promises and pitfalls of quantitative structure-activity relationship approaches for predicting metabolism and toxicity. , 2008, Chemical research in toxicology.
[11] A. Tsantili-Kakoulidou,et al. Application of quantitative structure–activity relationships for modeling drug and chemical transport across the human placenta barrier: a multivariate data analysis approach , 2009, Journal of applied toxicology : JAT.
[12] William A Watson,et al. Post-mortem Toxicology: What The Dead Can And Cannot Tell Us , 2003, Journal of toxicology. Clinical toxicology.
[13] B. Logan,et al. Lack of predictable site-dependent differences and time-dependent changes in postmortem concentrations of cocaine, benzoylecgonine, and cocaethylene in humans. , 1997, Journal of analytical toxicology.
[14] M. L. Ribeiro,et al. Quantitative method for the determination of organochlorine pesticides in serum. , 1996, Journal of analytical toxicology.
[15] C. L. Winek,et al. Drug and chemical blood-level data 2001. , 2001, Forensic science international.
[16] J. Mørland,et al. Postmortem drug redistribution--human cases related to results in experimental animals. , 1999, Journal of forensic sciences.
[17] R. Flanagan,et al. Interpretation of Analytical Toxicology Results in Life and at Postmortem , 2005, Toxicological reviews.
[18] A. Tsantili-Kakoulidou,et al. Quantitative structure-activity relationship (QSAR) methodology in forensic toxicology: modeling postmortem redistribution of structurally diverse drugs using multivariate statistics. , 2009, Forensic science international.
[19] W. H. Anderson,et al. The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. , 1990, Journal of forensic sciences.
[20] Timothy J Carlson,et al. Recent advances in high throughput screening for ADME properties. , 2008, Combinatorial chemistry & high throughput screening.
[21] Thomas Steger-Hartmann,et al. Use of computer-assisted prediction of toxic effects of chemical substances. , 2006, Toxicology.
[22] D. Garbutt,et al. A Comparison of Drug Concentrations in Postmortem Cardiac and Peripheral Blood in 320 Cases , 1995 .
[23] A. Vedani,et al. In silico prediction of harmful effects triggered by drugs and chemicals. , 2005, Toxicology and applied pharmacology.
[24] R. F. Shaw,et al. Concentrations of basic drugs in postmortem human myocardium. , 1982, Journal of toxicology. Clinical toxicology.
[25] E. Vuori,et al. Newer antidepressants: evaluation of fatal toxicity index and interaction with alcohol based on Finnish postmortem data , 2005, International Journal of Legal Medicine.
[26] C. E. Becker,et al. Key Concepts in Postmortem Drug Redistribution , 2005, Clinical toxicology.
[27] P. Marquet,et al. Mechanisms underlying postmortem redistribution of drugs: a review. , 2003, Journal of analytical toxicology.
[28] Maria Sandberg,et al. Multivariate Design and Modelling in QSAR, Combinatorial Chemistry, and Bioinformatics , 2000 .
[29] Kabrena E. Rodda,et al. The redistribution of selected psychiatric drugs in post-mortem cases. , 2006, Forensic science international.
[30] Robert A. Anderson,et al. Comparison of molecularly imprinted solid-phase extraction (MISPE) with classical solid-phase extraction (SPE) for the detection of benzodiazepines in post-mortem hair samples. , 2008, Forensic science international.
[31] Alexander Golbraikh,et al. Predictive QSAR modeling workflow, model applicability domains, and virtual screening. , 2007, Current pharmaceutical design.
[32] P. Marquet,et al. Post-mortem redistribution of three beta-blockers in the rabbit , 2006, International Journal of Legal Medicine.
[33] G. Jones,et al. Post-mortem drug redistribution--a toxicological nightmare. , 1990, Forensic science international.
[34] O. Drummer. Post-mortem toxicology. , 2007, Forensic science international.